Literature DB >> 33592118

Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.

Alec Bigness1, Iman Imanirad2, Ibrahim Halil Sahin2, Hao Xie2, Jessica Frakes3, Sarah Hoffe3, Danielle Laskowitz4, Seth Felder4.   

Abstract

Entities:  

Year:  2021        PMID： 33592118     DOI： 10.3322/caac.21661

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  5 in total

Review 1.  Role of MRI‑based radiomics in locally advanced rectal cancer (Review).

Authors:  Siyu Zhang; Mingrong Yu; Dan Chen; Peidong Li; Bin Tang; Jie Li
Journal:  Oncol Rep       Date:  2021-12-22       Impact factor: 3.906

2.  Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial.

Authors:  Shouki Bazarbashi; Mahmoud A Elshenawy; Ahmed Badran; Ali Aljubran; Ahmed Alzahrani; Hadeel Almanea; Abdullah Alsuhaibani; Ahmed Alashwah; Mohamed Neimatallah; Alaa Abduljabbar; Luai Ashari; Samar Alhomoud; Hazem Ghebeh; Tusneem Elhassan; Nasser Alsanea; Mohammed Mohiuddin
Journal:  Cancer Med       Date:  2022-02-10       Impact factor: 4.711

Review 3.  Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis.

Authors:  Zhou Ma; Ling Tan; Zi-Lin Liu; Jiang-Wei Xiao
Journal:  Front Surg       Date:  2022-08-26

4.  Multiple interventional embolizations for hemostasis in hemorrhage following advanced colorectal cancer treatment: a case report.

Authors:  Dongqiang Yang; Bo Shi; Yazhou Li; Yu Zhao; Ping Shi; Zhigang Li
Journal:  J Gastrointest Oncol       Date:  2022-08

5.  Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers.

Authors:  Xiaoyu Liu; Xu Xu; Zhuozhuo Wu; Qungang Shan; Ziyin Wang; Zhiyuan Wu; Xiaoyi Ding; Wei Huang; Zhongmin Wang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.